MENU
ABBV
AS OF
Nov 13, 04:59 PM (EDT)
Price
$232.35
Change
-$0.88 (-0.38%)
Capitalization
410.55B
82 days until earnings call
Intraday BUY SELL Signals
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2025 All rights reserved. Tickeron Inc.
ABBV
Stock ticker: NYSE
PRICE
CHANGE
CAPITALIZATION

ABBVIE (ABBV) Ownership - Who owns ABBVIE?

AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta)... Show more

#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
Pharmaceuticals Major
Address
1 North Waukegan Road
Phone
+1 847 932-7900
Employees
50000
Web
http://www.abbvieinvestor.com

Details

Group
Domestic Stock Funds
Category
Pharmaceuticals
Capitalization
410.55B
P/E Ratio
175.98
Total Cash
N/A
Projected Growth
0.42
Total Debt
70.48B
Revenue
58.33B
Risk (Beta)
N/A
Dividend Yield
0.03
Total Cash/Share
N/A
Total Debt/Equity
314.07
Revenue/Share
33.64 USD as % of share price

Fundamentals

ABBV
Capitalization
411B
P/E Ratio
175.98
Risk (Beta)
N/A
Dividend Yield
0.03
Total Cash
N/A
Total Cash/Share
N/A
Total Debt
70.5B
Total Debt/Equity
314.07
Projected Growth (PEG Ratio)
0.42
Revenue/Share (as % of the share price)
33.64%
Revenue
58.3B
ROE
N/A
Book Value
-183M
P/B Ratio
243.90
Cash Flow
N/A
Earnings
2.11
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
18M
Current Ratio
0.74
Current Revenue Per Employee
280418.20
Dividends Per Share - Security
1.64
EBITDA
14.2B
Float
N/A
Float - Current
N/A
Gross Income Margin
71.82
Revenue To Assets
2.67
Shares Held By Institutions
N/A
Shares Outstanding - Current
1.77B
Total Liabilities
7.06B
Total Volume MTD
N/A
Value
-1
Gain YTD
35.839
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
Day Trader: Search for Dip TA&FA ($1500)Day Trader: Search for Dip TA&FA ($1500)
Annualized Return+8%
VIEW DETAILSVIEW DETAILS
VIEW FOR FREEVIEW FOR FREE
ABBV
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. ABBV showed earnings on October 31, 2025. You can read more about the earnings report here.
View AI-Driven Trading for ABBV
A.I. Advisor
published General Information

General Information

a research-based pharmaceutical company

Industry PharmaceuticalsMajor

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
1 North Waukegan Road
Phone
+1 847 932-7900
Employees
50000
Web
http://www.abbvieinvestor.com